Survival in interstitial pulmonary fibrosis varies widely, and although the median survival after diagnosis is 2 to 3 years, the possibility of surviving more than a decade with the disease cannot be ruled out. Currently, the median survival after diagnosis of idiopathic pulmonary fibrosis is 2 to 3 years, but the course and outcome of the disease varies widely among individuals. Factors that affect the prognosis of patients with interstitial pulmonary fibrosis include, among others, dyspnea, decreased lung function and the degree of fibrosis and honeycomb-like changes in the lung tissue as demonstrated by high-resolution CT, and especially the dynamic changes in these parameters. Although pulmonary fibrosis is currently incurable, aggressive treatment can slow the progression of the disease and improve the patient’s quality of life, not excluding the possibility of a survival period of more than ten years. Treatments include antifibrotic drugs such as pirfenidone and nidanib, rehabilitation, and lung transplantation. If you feel unwell, please seek medical advice promptly.